Table 1.
Distribution of HCV genotypes in particular voivodeships among patients diagnosed between 1 January 2013 and 31 March 2016 in 29 centers; no data available for opolskie voivodeship. Estimations of G1a and G1b prevalence in all G1 patients based on the proportion of subgenotypes among those subgenotyped (G1a/G1b: 4/96) are shown in brackets
| n | Genotypes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 All | 1a | 1b | 1 Other* | 2 | 3 | 4 | 5 | 6 | ||
| 8321 | 239 | 6135 | 1947 | 21 | 1113 | 339 | 1 | 5 | ||
| Poland | 9800 | 84.9% | 2.4% (3.2%) | 62.6% (81.7%) | 19.9% | 0.2% | 11.3% | 3.5% | 0% | 0.1% |
| Voivodeships | ||||||||||
| podlaskie | 184 | 70.1% | 3.3% | 66.8% | 0% | 0.5% | 17.4% | 11.4% | 0% | 0.5% |
| lubuskie | 536 | 72.2% | 6.2% | 62.9% | 3.2% | 0.4% | 20.5% | 6.9% | 0% | 0% |
| podkarpackie | 137 | 72.3% | 2.2% | 69.3% | 0.7% | 0% | 17.5% | 10.2% | 0% | 0% |
| dolnośląskie | 1000 | 74.7% | 1.7% | 28.0% | 45.0% | 0.2% | 20.9% | 4.2% | 0% | 0% |
| warmińsko-mazurskie | 202 | 76.2% | 0.5% | 51.0% | 24.8% | 0.5% | 16.8% | 5.9% | 0.5% | 0% |
| kujawsko-pomorskie | 523 | 79.2% | 0.4% | 14.9% | 63.9% | 0% | 11.7% | 8.8% | 0% | 0.4% |
| pomorskie | 531 | 80.0% | 0.0% | 20.3% | 59.7% | 0.6% | 15.3% | 4.0% | 0% | 0.2% |
| mazowieckie | 1428 | 86.7% | 2.7% | 79.1% | 4.8% | 0.2% | 9.9% | 3.2% | 0% | 0% |
| wielkopolskie | 426 | 87.8% | 10.1% | 70.2% | 7.5% | 0% | 8.7% | 3.5% | 0% | 0% |
| śląskie | 2189 | 88.8% | 1.0% | 81.7% | 6.1% | 0.2% | 9.5% | 1.6% | 0% | 0% |
| zachodniopomorskie | 57 | 89.5% | 1.8% | 78.9% | 8.8% | 0% | 5.3% | 5.3% | 0% | 0% |
| świętokrzyskie | 380 | 89.7% | 0.3% | 89.5% | 0% | 0% | 7.1% | 3.2% | 0% | 0% |
| małopolskie | 918 | 90.3% | 2.0% | 81.7% | 6.6% | 0.2% | 7.5% | 2.0% | 0% | 0% |
| łódzkie | 895 | 92.2% | 5.8% | 47.9% | 38.4% | 0.1% | 6.4% | 1.2% | 0% | 0.1% |
| lubelskie | 394 | 92.6% | 0.5% | 58.4% | 33.8% | 0.3% | 5.1% | 2.0% | 0% | 0% |
*
Genotype 1 without subgenotyping